drugset / Trial / NCT00542685
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will evaluate the efficacy and safety of PD 0332334 for the treatment of generalized anxiety disorder.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMAGABALIN | Other / unclassified | 175 mg | Oral |
| Subject | IMAGABALIN | Other / unclassified | 225 mg | Oral |
| Subject | IMAGABALIN | Other / unclassified | 300 mg | Oral |